Basics Vaxcyte, Inc. IPO Date: July 12, 2020 Sector: Healthcare Industry: Biotech Market Cap: $6.08B Activated in VL: True Average Daily Range Avg Daily Range: $1.02 | 2.53% Avg Daily Range (30 D): $1.06 | 2.38% Avg Daily Range (90 D): $0.82 | 2.11% Institutional Daily Volume Avg Daily Volume: .62M Avg Daily Volume (30 D): 1.24M Avg Daily Volume (90 D): 1.36M Trade Size Avg Trade Size (Sh.): 60 Avg Trade Size (Sh.) (30 D): 56 Avg Trade Size (Sh.) (90 D): 60 Institutional Trades Total Inst.Trades: 3,720 Avg Inst. Trade: $3.68M Avg Inst. Trade (30 D): $2.76M Avg Inst. Trade (90 D): $3.03M Avg Inst. Trade Volume: .07M Avg Inst. Trades (Per Day): 3 Market Closing Trades Avg Closing Trade: $7.44M Avg Closing Trade (30 D): $7.59M Avg Closing Trade (90 D): $8.25M Avg Closing Volume: 142.28K     News Sep 30, 2025 @ 3:42 PM Thermo Fisher Launches Four-Part Bond Offering Ahe... Source: Vandana Singh Aug 21, 2025 @ 5:00 PM Pneumococcal Infections Clinical Trial Analysis: K... Source: Delveinsight Aug 7, 2025 @ 12:19 AM Vaxcyte (PCVX) Q2 Loss Widens 11% Source: Jesterai Mar 31, 2025 @ 12:56 PM Vaxcyte Plans To Drop Developing One Pneumococcal ... Source: Vandana Singh Jan 30, 2025 @ 4:51 PM Kuehn Law Encourages Investors of Vaxcyte, Inc. to... Source: N/A Financials   TTM Q3 2025 Q2 2025 Basic EPS $-4.84 $-1.56 $-1.22 Diluted EPS $-4.84 $-1.56 $-1.22 Revenue $ M $ M $ M Gross Profit $ $ $ Net Income / Loss $ -657.2M $ -212.83M $ -166.57M Operating Income / Loss $ -811.56M $ -242.38M $ -226.22M Cost of Revenue $ $ $ Net Cash Flow $ -768.96M $ -25.52M $ -40.11M PE Ratio